Cargando…

Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues

BACKGROUND: Nicotinic acetylcholine receptors (nAChRs) play an important role in cellular physiology and human nicotine dependence, and are closely associated with many human diseases including cancer. For example, previous studies suggest that nAChRs can re-wire gene regulatory networks in lung can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Madden, Pamela, Gu, Junchen, Xing, Xiaoyun, Sankar, Savita, Flynn, Jennifer, Kroll, Kristen, Wang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460472/
https://www.ncbi.nlm.nih.gov/pubmed/28583088
http://dx.doi.org/10.1186/s12864-017-3813-4
_version_ 1783242182205898752
author Zhang, Bo
Madden, Pamela
Gu, Junchen
Xing, Xiaoyun
Sankar, Savita
Flynn, Jennifer
Kroll, Kristen
Wang, Ting
author_facet Zhang, Bo
Madden, Pamela
Gu, Junchen
Xing, Xiaoyun
Sankar, Savita
Flynn, Jennifer
Kroll, Kristen
Wang, Ting
author_sort Zhang, Bo
collection PubMed
description BACKGROUND: Nicotinic acetylcholine receptors (nAChRs) play an important role in cellular physiology and human nicotine dependence, and are closely associated with many human diseases including cancer. For example, previous studies suggest that nAChRs can re-wire gene regulatory networks in lung cancer cell lines. However, the tissue specificity of nAChRs genes and their regulation remain unexplored. RESULT: In this study, we integrated data from multiple large genomic consortiums, including ENCODE, Roadmap Epigenomics, GTEx, and FANTOM, to define the transcriptomic and epigenomic landscape of all nicotinic receptor genes across many different human tissues and cell types. We found that many important nAChRs, including CHRNA3, CHRNA4, CHRNA5, and CHRNB4, exhibited strong non-neuronal tissue-specific expression patterns. CHRNA3, CHRNA5, and CHRNB4 were highly expressed in human colon and small intestine, and CHRNA4 was highly expressed in human liver. By comparing the epigenetic marks of CHRNA4 in human liver and hippocampus, we identified a novel liver-specific transcription start site (TSS) of CHRNA4. We further demonstrated that CHRNA4 was specifically transcribed in hepatocytes but not transcribed in hepatic sinusoids and stellate cells, and that transcription factors HNF4A and RXRA were likely upstream regulators of CHRNA4. Our findings suggest that CHRNA4 has distinct transcriptional regulatory mechanisms in human liver and brain, and that this tissue-specific expression pattern is evolutionarily conserved in mouse. Finally, we found that liver-specific CHRNA4 transcription was highly correlated with genes involved in the nicotine metabolism, including CYP2A6, UGT2B7, and FMO3. These genes were significantly down-regulated in liver cancer patients, whereas CHRNA4 is also significantly down-regulated in cancer-matched normal livers. CONCLUSIONS: Our results suggest important non-neuronally expressed nicotinic acetylcholine receptors in the human body. These non-neuronal expression patterns are highly tissue-specific, and are epigenetically conserved during evolution in the context of non-conserved DNA sequence. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-017-3813-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5460472
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54604722017-06-07 Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues Zhang, Bo Madden, Pamela Gu, Junchen Xing, Xiaoyun Sankar, Savita Flynn, Jennifer Kroll, Kristen Wang, Ting BMC Genomics Research Article BACKGROUND: Nicotinic acetylcholine receptors (nAChRs) play an important role in cellular physiology and human nicotine dependence, and are closely associated with many human diseases including cancer. For example, previous studies suggest that nAChRs can re-wire gene regulatory networks in lung cancer cell lines. However, the tissue specificity of nAChRs genes and their regulation remain unexplored. RESULT: In this study, we integrated data from multiple large genomic consortiums, including ENCODE, Roadmap Epigenomics, GTEx, and FANTOM, to define the transcriptomic and epigenomic landscape of all nicotinic receptor genes across many different human tissues and cell types. We found that many important nAChRs, including CHRNA3, CHRNA4, CHRNA5, and CHRNB4, exhibited strong non-neuronal tissue-specific expression patterns. CHRNA3, CHRNA5, and CHRNB4 were highly expressed in human colon and small intestine, and CHRNA4 was highly expressed in human liver. By comparing the epigenetic marks of CHRNA4 in human liver and hippocampus, we identified a novel liver-specific transcription start site (TSS) of CHRNA4. We further demonstrated that CHRNA4 was specifically transcribed in hepatocytes but not transcribed in hepatic sinusoids and stellate cells, and that transcription factors HNF4A and RXRA were likely upstream regulators of CHRNA4. Our findings suggest that CHRNA4 has distinct transcriptional regulatory mechanisms in human liver and brain, and that this tissue-specific expression pattern is evolutionarily conserved in mouse. Finally, we found that liver-specific CHRNA4 transcription was highly correlated with genes involved in the nicotine metabolism, including CYP2A6, UGT2B7, and FMO3. These genes were significantly down-regulated in liver cancer patients, whereas CHRNA4 is also significantly down-regulated in cancer-matched normal livers. CONCLUSIONS: Our results suggest important non-neuronally expressed nicotinic acetylcholine receptors in the human body. These non-neuronal expression patterns are highly tissue-specific, and are epigenetically conserved during evolution in the context of non-conserved DNA sequence. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-017-3813-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-05 /pmc/articles/PMC5460472/ /pubmed/28583088 http://dx.doi.org/10.1186/s12864-017-3813-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Bo
Madden, Pamela
Gu, Junchen
Xing, Xiaoyun
Sankar, Savita
Flynn, Jennifer
Kroll, Kristen
Wang, Ting
Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
title Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
title_full Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
title_fullStr Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
title_full_unstemmed Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
title_short Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
title_sort uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460472/
https://www.ncbi.nlm.nih.gov/pubmed/28583088
http://dx.doi.org/10.1186/s12864-017-3813-4
work_keys_str_mv AT zhangbo uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT maddenpamela uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT gujunchen uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT xingxiaoyun uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT sankarsavita uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT flynnjennifer uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT krollkristen uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues
AT wangting uncoveringthetranscriptomicandepigenomiclandscapeofnicotinicreceptorgenesinnonneuronaltissues